Plasma Fractionation Market Outlook 2026, Key Trends, Growth Drivers, and Strategic Industry Forecast

Pune, India: The global Plasma Fractionation market is brilliantly evaluated in the research study that explores vital aspects such as market competition, segmentation, revenue and production growth, and regional expansion. The authors of the report have provided a thorough assessment of the global Plasma Fractionation market on the basis of CAGR, sales, consumption, price, gross margin, and other significant factors. We have studied key players of the global Plasma Fractionation market, taking into account their recent developments, geographical market growth, footprint, market expansion, production, and areas served. Our key findings and recommendations have proven quite helpful for both established and new players in the global Plasma Fractionation market.

The global Plasma Fractionation market was valued at US$ 37710 million in 2025 and is anticipated to reach US$ 62130 million by 2032, witnessing a CAGR of 7.5% during the forecast period 2026-2032.

Get PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.qyresearch.in/request-sample/medical-devices-consumables-global-plasma-fractionation-market-insights-industry-share-sales-projections-and-demand-outlook-2026-2032

Market Drivers:

Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the blood plasma fractionation market.

Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the plasma fractionation market.

Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for blood plasma fractionation to produce these therapies.

Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.

Market Challenges:

High Costs of Plasma-Derived Products: The complex and time-consuming process of plasma fractionation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.

Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.

Stringent Regulatory Framework: Plasma fractionation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.

Complex Manufacturing Process: The plasma fractionation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.

The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.

The classification of Blood Plasma Fractionation includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Blood Plasma Fractionation market.

North America is the largest consumption place, with a revenue market share nearly 40 % in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Blood Plasma Fractionation.

Competitive Landscape

Leading players of the global Plasma Fractionation market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global Plasma Fractionation market. Furthermore, the report offers two separate market forecasts - one for the production side and another for the consumption side of the global Plasma Fractionation market. It also provides useful recommendations for new as well as established players of the global Plasma Fractionation market.

Key Players Mentioned in the Global Plasma Fractionation Market Research Report:

Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics

Market Segmentation

Our market analysts are experts in deeply segmenting the global Plasma Fractionation market and thoroughly evaluating the growth potential of each and every segment studied in the report. Right at the beginning of the research study, the segments are compared on the basis of consumption and growth rate for a review period of nine years. The segmentation study included in the report offers a brilliant analysis of the global Plasma Fractionation market, taking into consideration the market potential of different segments studied. It assists market participants to focus on high-growth areas of the global Plasma Fractionation market and plan powerful business tactics to secure a position of strength in the industry.

Segment by Type:

Albumin
Immune Globulin
Coagulation Factor
Others

Segment by Application:

Hospital
Retail Pharmacy
Other

Regional Insights

Plasma Fractionation market research study is incomplete without regional analysis, and we are well aware of it. That is why, the report includes a comprehensive and all-inclusive study that solely concentrates on the geographical growth of the global Plasma Fractionation market. The study also includes accurate estimations about market growth at the global, regional, and country levels. It empowers you to understand why some regional markets are flourishing while others are seeing a decline in growth. It also allows you to focus on geographies that hold the potential to create lucrative prospects in the near future.

Five-Year Outlook for Investors, Researchers, and Manufacturers (2025-2031)

If you are looking for the best route to enter or establish your business in the global Plasma Fractionation market, you can use our report that offers top market analysis and advice. Our route-to-market analytics will help you to maximize your revenue generation. We have sufficient domain knowledge and expertise in supply chain management to provide the best route-to-market analytics. Furthermore, our analysts are experts in providing in-depth market analysis, which means you will be exposed to some great insights into critical aspects of the global Plasma Fractionation market.

The encyclopedic research study offers analysis that will help you to optimally manage your business portfolio as you take a multi-level strategic approach. The report focuses on downstream and upstream growth prospects, the benchmarking of business segments to allow selections on the basis of long-term growth, and micro-level as well as macro-level analysis of the global Plasma Fractionation market. We also provide granular level analysis where segments are analyzed on a singular level while offering key market forecasts, estimations, and analysis.

The report can also be used as a resource for distribution network management and partner selection. Starting with the dissection of the industry value chain, we provide complete research on distribution and vendor management. Our research will help you to minimize distribution costs and also help you with selection as we benchmark vendors. You will be able to identify appropriate vendors and channel partners and find earning and profit margin opportunities across the global Plasma Fractionation market with the help of backward and forward integration. In addition, we provide insights about key market players of the global Plasma Fractionation market and their presence in the distribution network.

What to expect in our report?

(1) A complete section of the Plasma Fractionation market report is dedicated for market dynamics, which include influence factors, market drivers, challenges, opportunities, and trends.

(2) Another broad section of the research study is reserved for regional analysis of the global Plasma Fractionation market where important regions and countries are assessed for their growth potential, consumption, market share, and other vital factors indicating their market growth.

(3) Players can use the competitive analysis provided in the report to build new strategies or fine-tune their existing ones to rise above market challenges and increase their share of the global Plasma Fractionation market.

(4) The report also discusses competitive situation and trends and sheds light on company expansions and merger and acquisition taking place in the global Plasma Fractionation market. Moreover, it brings to light the market concentration rate and market shares of top three and five players.

(5) Readers are provided with findings and conclusion of the research study provided in the Plasma Fractionation Market report.

Request Pre-Order Enquiry or Customized Research On This Report: https://www.qyresearch.in/pre-order-inquiry/medical-devices-consumables-global-plasma-fractionation-market-insights-industry-share-sales-projections-and-demand-outlook-2026-2032

Table of Content

"1 Plasma Fractionation Market Overview
1.1 Product Definition
1.2 Plasma Fractionation Market by Type
1.2.1 Global Plasma Fractionation Market Value by Type (2021-2032)
1.2.2 Albumin
1.2.3 Immune Globulin
1.2.4 Coagulation Factor
1.2.5 Others
1.3 Plasma Fractionation by Application
1.3.1 Global Plasma Fractionation Market Value by Application (2021-2032)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Global Plasma Fractionation Revenue (2021-2032)
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Key Insights
2.1 Key Emerging Trends
2.2 Key Developments - Mergers Acquisitions, New Product Launches, Collaborations, Partnerships and Joint Ventures
2.3 Latest Technological Advancements
2.4 Insights on Regulatory Scenarios
2.5 Porters Five Forces Analysis
3 Players Competitive Analysis
3.1 Global Plasma Fractionation Revenue by Player (2021-2026)
3.2 Plasma Fractionation Company Evaluation Quadrant
3.3 Industry Rank
3.3.1 Global Key Players of Plasma Fractionation, Industry Ranking, 2024 VS 2025
3.3.2 Global Plasma Fractionation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3.3 Global Plasma Fractionation Market Concentration Rate
3.3.4 Global 5 and 10 Largest Plasma Fractionation Players Market Share by Revenue
3.4 Plasma Fractionation Market: Overall Company Footprint Analysis
3.4.1 Plasma Fractionation Market: Region Footprint
3.4.2 Plasma Fractionation Market: Company Product Type Footprint
3.4.3 Plasma Fractionation Market: Company Product Application Footprint
3.4.4 Global Key Players of Plasma Fractionation, Date of Enter into This Industry
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
4 Players Profiles
4.1 Takeda
4.1.1 Takeda Company Details
4.1.2 Takeda Business Overview
4.1.3 Takeda Plasma Fractionation Introduction
4.1.4 Takeda Revenue in Plasma Fractionation Business (2021-2026)
4.1.5 Takeda Recent Development
4.2 CSL
4.2.1 CSL Company Details
4.2.2 CSL Business Overview
4.2.3 CSL Plasma Fractionation Introduction
4.2.4 CSL Revenue in Plasma Fractionation Business (2021-2026)
4.2.5 CSL Recent Development
4.3 Grifols
4.3.1 Grifols Company Details
4.3.2 Grifols Business Overview
4.3.3 Grifols Plasma Fractionation Introduction
4.3.4 Grifols Revenue in Plasma Fractionation Business (2021-2026)
4.3.5 Grifols Recent Development
4.4 Octapharma
4.4.1 Octapharma Company Details
4.4.2 Octapharma Business Overview
4.4.3 Octapharma Plasma Fractionation Introduction
4.4.4 Octapharma Revenue in Plasma Fractionation Business (2021-2026)
4.4.5 Octapharma Recent Development
4.5 Kedrion
4.5.1 Kedrion Company Details
4.5.2 Kedrion Business Overview
4.5.3 Kedrion Plasma Fractionation Introduction
4.5.4 Kedrion Revenue in Plasma Fractionation Business (2021-2026)
4.5.5 Kedrion Recent Development
4.6 LFB Group
4.6.1 LFB Group Company Details
4.6.2 LFB Group Business Overview
4.6.3 LFB Group Plasma Fractionation Introduction
4.6.4 LFB Group Revenue in Plasma Fractionation Business (2021-2026)
4.6.5 LFB Group Recent Development
4.7 Biotest
4.7.1 Biotest Company Details
4.7.2 Biotest Business Overview
4.7.3 Biotest Plasma Fractionation Introduction
4.7.4 Biotest Revenue in Plasma Fractionation Business (2021-2026)
4.7.5 Biotest Recent Development
4.8 BPL
4.8.1 BPL Company Details
4.8.2 BPL Business Overview
4.8.3 BPL Plasma Fractionation Introduction
4.8.4 BPL Revenue in Plasma Fractionation Business (2021-2026)
4.8.5 BPL Recent Development
4.9 RAAS
4.9.1 RAAS Company Details
4.9.2 RAAS Business Overview
4.9.3 RAAS Plasma Fractionation Introduction
4.9.4 RAAS Revenue in Plasma Fractionation Business (2021-2026)
4.9.5 RAAS Recent Development
4.10 CBPO
4.10.1 CBPO Company Details
4.10.2 CBPO Business Overview
4.10.3 CBPO Plasma Fractionation Introduction
4.10.4 CBPO Revenue in Plasma Fractionation Business (2021-2026)
4.10.5 CBPO Recent Development
4.11 Hualan Bio
4.11.1 Hualan Bio Company Details
4.11.2 Hualan Bio Business Overview
4.11.3 Hualan Bio Plasma Fractionation Introduction
4.11.4 Hualan Bio Revenue in Plasma Fractionation Business (2021-2026)
4.11.5 Hualan Bio Recent Development
4.12 Tiantan Bio
4.12.1 Tiantan Bio Company Details
4.12.2 Tiantan Bio Business Overview
4.12.3 Tiantan Bio Plasma Fractionation Introduction
4.12.4 Tiantan Bio Revenue in Plasma Fractionation Business (2021-2026)
4.12.5 Tiantan Bio Recent Development
4.13 Shuanglin Bio
4.13.1 Shuanglin Bio Company Details
4.13.2 Shuanglin Bio Business Overview
4.13.3 Shuanglin Bio Plasma Fractionation Introduction
4.13.4 Shuanglin Bio Revenue in Plasma Fractionation Business (2021-2026)
4.13.5 Shuanglin Bio Recent Development
4.14 Boya Bio
4.14.1 Boya Bio Company Details
4.14.2 Boya Bio Business Overview
4.14.3 Boya Bio Plasma Fractionation Introduction
4.14.4 Boya Bio Revenue in Plasma Fractionation Business (2021-2026)
4.14.5 Boya Bio Recent Development
4.15 Yuanda Shuyang
4.15.1 Yuanda Shuyang Company Details
4.15.2 Yuanda Shuyang Business Overview
4.15.3 Yuanda Shuyang Plasma Fractionation Introduction
4.15.4 Yuanda Shuyang Revenue in Plasma Fractionation Business (2021-2026)
4.15.5 Yuanda Shuyang Recent Development
4.16 Weiguang Bio
4.16.1 Weiguang Bio Company Details
4.16.2 Weiguang Bio Business Overview
4.16.3 Weiguang Bio Plasma Fractionation Introduction
4.16.4 Weiguang Bio Revenue in Plasma Fractionation Business (2021-2026)
4.16.5 Weiguang Bio Recent Development
4.17 Nanyue Bio
4.17.1 Nanyue Bio Company Details
4.17.2 Nanyue Bio Business Overview
4.17.3 Nanyue Bio Plasma Fractionation Introduction
4.17.4 Nanyue Bio Revenue in Plasma Fractionation Business (2021-2026)
4.17.5 Nanyue Bio Recent Development
4.18 KM Biologics
4.18.1 KM Biologics Company Details
4.18.2 KM Biologics Business Overview
4.18.3 KM Biologics Plasma Fractionation Introduction
4.18.4 KM Biologics Revenue in Plasma Fractionation Business (2021-2026)
4.18.5 KM Biologics Recent Development
5 Analysis by Region
5.1 Global Plasma Fractionation Market Size by Region
5.1.1 Global Plasma Fractionation Revenue by Region: 2021 VS 2025 VS 2032
5.1.2 Global Plasma Fractionation Revenue by Region (2021-2026)
5.1.3 Global Plasma Fractionation Revenue by Region (2027-2032)
5.1.4 Global Plasma Fractionation Revenue Market Share by Region (2021-2032)
5.2 North America Plasma Fractionation Revenue (2021-2032)
5.3 Europe Plasma Fractionation Revenue (2021-2032)
5.4 Asia-Pacific Plasma Fractionation Revenue (2021-2032)
5.5 South America Plasma Fractionation Revenue (2021-2032)
5.6 Middle East & Africa Plasma Fractionation Revenue (2021-2032)
6 Market Scenario by Region & Country
6.1 Global Plasma Fractionation Revenue by Region & Country: 2021 VS 2025 VS 2032
6.2 Global Plasma Fractionation Revenue by Region & Country (2021-2032)
6.3 North America Plasma Fractionation Market Facts & Figures by Country
6.3.1 North America Plasma Fractionation Revenue by Country: 2021 VS 2025 VS 2032
6.3.2 North America Plasma Fractionation Revenue by Country (2021-2032)
6.3.3 United States
6.3.4 Canada
6.4 Europe Plasma Fractionation Market Facts & Figures by Country
6.4.1 Europe Plasma Fractionation Revenue by Country: 2021 VS 2025 VS 2032
6.4.2 Europe Plasma Fractionation Revenue by Country (2021-2032)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Russia
6.5 Asia Pacific Plasma Fractionation Market Facts & Figures by Region
6.5.1 Asia Pacific Plasma Fractionation Market Size by Region: 2021 VS 2025 VS 2032
6.5.2 Asia Pacific Plasma Fractionation Revenue by Region (2021-2032)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 India
6.5.7 Australia
6.5.8 China Taiwan
6.5.9 Indonesia
6.5.10 Thailand
6.5.11 Malaysia
6.5.12 Philippines
6.6 South America Plasma Fractionation Market Facts & Figures by Country
6.6.1 South America Plasma Fractionation Market Size by Country: 2021 VS 2025 VS 2032
6.6.2 South America Plasma Fractionation Revenue by Country
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Argentina
6.7 Middle East and Africa Plasma Fractionation Market Facts & Figures by Country
6.7.1 Middle East and Africa Plasma Fractionation Market Size by Country: 2021 VS 2025 VS 2032
6.7.2 Middle East and Africa Plasma Fractionation Revenue by Country
6.7.3 Turkey
6.7.4 Saudi Arabia
6.7.5 U.A.E
7 Segment by Type
7.1 Global Plasma Fractionation Revenue by Type (2021-2026)
7.2 Global Plasma Fractionation Revenue by Type (2027-2032)
7.3 Global Plasma Fractionation Revenue Market Share by Type (2021-2032)
8 Segment by Application
8.1 Global Plasma Fractionation Revenue by Application (2021-2026)
8.2 Global Plasma Fractionation Revenue by Application (2027-2032)
8.3 Global Plasma Fractionation Revenue Market Share by Application (2021-2032)
9 Industry Chain and Sales Channels Analysis
9.1 Plasma Fractionation Industry Chain Analysis
9.2 Plasma Fractionation Key Raw Materials
9.2.1 Key Raw Materials
9.2.2 Raw Materials Key Suppliers
9.3 Plasma Fractionation Production Mode & Process
9.4 Plasma Fractionation Sales and Marketing
9.4.1 Plasma Fractionation Sales Channels
9.4.2 Plasma Fractionation Distributors
9.5 Plasma Fractionation Customers
10 Research Findings and Conclusion
11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Author Details
11.3 Disclaimer

About US:

QYResearch is a leading global market research and consulting company established in 2007. With over 18 years' experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability.

Contact US

Ankit Jain - Director, Global Digital Marketing

QY Research, INC.
India Office -
315Work Avenue, Raheja Woods, Kalyani Nagar,
Pune, Maharashtra 411006, India
Web - https://www.qyresearch.in
Email- ankit@qyresearch.com

This release was published on openPR.